Yaw Bediako, PhD joined a distinguished panel of Ghana’s healthcare leaders and government representatives to engage the public on the nation’s COVID-19 vaccine roll out plan. The event, held on 19th February 2021 at Alisa Hotel North Ridge and broadcast live on national television, was hosted by the Minister of Information Designate Hon. Kojo Oppong Nkrumah. The speakers included the Minister of Health Designate Hon. Kwaku Agyeman-Manu, the Director General of Ghana Health Service Hon. Dr. Patrick Kuma-Aboagye, the Programme Manager of the Expanded Programme on Immunisation, Dr. Kwame Amponsa-Achiano, and the Chief Executive Officer of the Ghana Food and Drugs Authority, Mrs. Delese Mimi Darko.
Dr. Bediako presented a brief history of vaccinations, from events leading up to the first vaccine administration in 1796 to the more recent developments of the Ebola and COVID-19 vaccines in 2019 and 2020 respectively. He illustrated the huge impact vaccinations have made on the significant decline of cases of diseases like diphtheria, poliomyelitis and measles globally and in Ghana.
He also explained how vaccines work in general, discussed the three main approaches to making a vaccine, and broke down the three phases of clinical trials through which the safety and efficacy of vaccines are tested. He stressed that the COVID-19 vaccines currently in use worldwide have undergone rigorous validation processes, and have been approved for use by the World Health Organization.
Dr. Bediako also shared the remarkable progress made by other countries like Israel and the UK in vaccinating large percentages of their population against COVID-19, noting that very few negative reactions have been reported. He went on to dispel some of the popular myths causing fear and distrust of the COVID-19 vaccine in Ghana, and encouraged Ghanaians to embrace the vaccine, saying “the single most effective immune booster you can take is a vaccine”.
The Ghana FDA has granted emergency authorization for the use of two vaccines: Covishield (AstraZeneca) and Sputnik V. The first shipment of 350,000 doses of the AstraZeneca vaccine is expected to arrive in Ghana in late February 2021
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
|cookielawinfo-checbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.